Agenda

Return

C.36

To:	Board of Supervisors
From:	William Walker, M.D., Health Services Director
Date:	December 8, 2009

Contra

Costa

County

Subject:

Notice of Award #29-393-12 from the State of California, Tuberculosis Control Branch

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 12/08/2009

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Gayle B. Uilkema, District II Supervisor
Mary N. Piepho, District III Supervisor
Susan A. Bonilla, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Wendel Brunner, M.D 313-6712
cc:	J. Pigg B. Borbon

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: December 8, 2009
David Twa,

BY:	, Deputy

RECOMMENDATION(S):

Approve and authorize the Health Services Director or his designee (Wendel Brunner, M.D.), to accept an award (County #29-393-12), from the State of California, Tuberculosis Control Branch, to pay the County an amount not to exceed $331,949, for the period from July 1, 2009 through June 30, 2010, for the Tuberculosis (TB) Control Program.

FISCAL IMPACT:

Acceptance of this Award will result in a total of $331,949 from the State of California, Tuberculosis Control Branch for fiscal year 2009-2010. No County funds are required

BACKGROUND:

The Contra Costa County, Public Health Department maintains a TB Control Program, which serves all reported TB patients and their contacts in Contra Costa County. Outreach services are provided to reach the “Hard-to Reach” people with TB and those at high risk. The TB control staff work within the Communicable Disease Section in collaboration with the HIV/AIDS Program, Substance Abuse Programs, Contra Costa Regional Medical Center and Health Centers, and providers throughout the County.

Acceptance of this Award will allow the Department to: (1) continue to expand prevention and control activities, and (2) improve completion of appropriate therapy which is essential to decrease TB transmission, prevent the development of drug resistance, and cure TB patients, through June 30, 2010.